ctrl K

Advertisement

Kinnate Biopharma Inc. (KNTE)

NASDAQ: KNTE · Real-Time Price · USD

2.65

-0.01 (-0.38%)

At close: Apr 02, 2024, 8:00 PM

Kinnate Biopharma Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	799K	604K	123K	83K	n/a	n/a
Gross Profit	-799K	-604K	-123K	-83K	n/a	n/a
Operating Income	-119.01M	-118.52M	-90.11M	-36M	-12.01M	-7.63M
Interest Income	8.53M	n/a	348K	245K	43K	n/a
Pretax Income	-112.65M	-116.27M	-89.76M	-35.76M	-11.97M	-7.63M
Net Income	-112.65M	-114.02M	-89.42M	-35.43M	-11.93M	-7.63M
Selling & General & Admin	27.44M	30.37M	22.95M	6.76M	3.06M	1.96M
Research & Development	90.77M	88.15M	67.17M	29.24M	8.96M	5.67M
Other Expenses	n/a	2.25M	348K	-5K	n/a	n/a
Operating Expenses	118.21M	118.52M	90.11M	36M	12.01M	7.63M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	119.01M	118.52M	90.11M	36M	12.01M	7.63M
Income Tax Expense	n/a	-2.25M	-348K	-328K	-43K	n/a
Shares Outstanding (Basic)	46.58M	44.07M	43.6M	43.48M	43.33M	10.8M
Shares Outstanding (Diluted)	46.58M	44.07M	43.6M	43.48M	43.33M	10.8M
EPS (Basic)	-2.42	-2.59	-2.05	-0.81	-0.28	-0.71
EPS (Diluted)	-2.42	-2.59	-2.05	-0.81	-0.28	-0.71
EBITDA	-118.21M	-117.92M	-89.99M	-35.92M	-12.01M	-7.63M
EBIT	n/a	n/a	n/a	n/a	n/a	n/a
Depreciation & Amortization	799K	604K	123K	83K	171.86K	161.14K